Consistent with this hypothesis, data gathered in the Prostate Cancer Transcriptome Atlas [62], comprising over 1300 clinical specimens from 38 cohorts, show a significant reduction of SULF1 expression in metastatic castrate-resistant PCa compared to benign and primary tumors (S11 Fig). The gene discussed is SULF1; the disease is prostate cancer.